Please orient your device to the portrait position
to return to the site

Step-by-Step

Getting started on XOLAIR is a little different from other medications. Once your doctor gives you your prescription, there are a few steps that take place before you get your first XOLAIR injection. In most cases, these steps take about 2 weeks.

Take the XOLAIR guided tour

The steps below show you what may lie ahead if your doctor prescribes XOLAIR for your moderate to severe persistent allergic asthma. If you’d like, you can print out a checklist to keep track of where you are in the process.

 

Download Checklist

To view PDF files, Adobe® Reader® must be installed on your computer. If you do not have this program,
download it now for free.

Steps to Starting XOLAIR

 

Signing forms

Your doctor writes a prescription for XOLAIR and completes a Statement of Medical Necessity (SMN). You sign the Patient Authorization and Notice of Release of Information (PAN). Your doctor sends both of these forms to a specialty pharmacy or XOLAIR Access Solutions.

  • Specialty pharmacy—a type of pharmacy with expertise in certain conditions and injectable medications like XOLAIR
  • XOLAIR Access Solutions—helps you find out your coverage and connects you with patient assistance programs

Checking coverage

Your specialty pharmacy or XOLAIR Access Solutions lets you know if your health plan covers XOLAIR.

  • Most health plans cover XOLAIR, but you may need prior authorization (PA). XOLAIR Access Solutions can work with your doctor's office to see if you need a PA
  • If you don't have a healthcare plan to pay for XOLAIR, the Genentech® Access to Care Foundation (GATCF) may be able to help. GATCF helps qualified patients receive their medicine free of charge.

Verifying information

The Specialty Pharmacy contacts you to check your information.

  • Remember to always return phone calls from the Specialty Pharmacy. This helps make sure your health plan and Specialty Pharmacy have all the information they need.
  • Just be aware that if the Specialty Pharmacy calls and leaves a message, they may not mention XOLAIR or provide detailed information due to privacy laws.

Shipping XOLAIR

You tell The Specialty Pharmacy where to ship XOLAIR (wherever you will be receiving your injections) and pay any co-pay to the Specialty Pharmacy before they deliver it.

Assistance programs

If you are concerned about paying for XOLAIR or if your health plan doesn't cover XOLAIR, XOLAIR Access Solutions can find out if you qualify for one of our other Patient Assistance Programs.

Your XOLAIR might not come from a specialty pharmacy. Instead, your doctor might buy XOLAIR and get paid by your health plan for the cost of the medicine (called "buy and bill"). In this case, XOLAIR Access Solutions can still help check your coverage and find assistance with co-pays. You and your doctor just have to fill out the SMN and PAN forms to get started.

Access Solutions
Print

You last added:

    0

    What is XOLAIR?

    XOLAIR® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat adults and children 12 years of age and older with moderate to severe persistent asthma whose asthma symptoms are not controlled by asthma medicines called inhaled corticosteroids. A skin or blood test is performed to see if you have allergies to year-round allergens.

    XOLAIR is not used to treat other allergic conditions, acute bronchospasm or status asthmaticus.

    IMPORTANT SAFETY INFORMATION

    What is the most important information I should know about XOLAIR?

    A severe allergic reaction called anaphylaxis can happen when you receive XOLAIR. The reaction can occur after the first dose, or after many doses. It may also occur right after a XOLAIR injection or days later. Anaphylaxis is a life-threatening condition and can lead to death. Go to the nearest emergency room right away if you have any of these symptoms of an allergic reaction:

    • wheezing, shortness of breath, cough, chest tightness, or trouble breathing
    • low blood pressure, dizziness, fainting, rapid or weak heartbeat, anxiety, or feeling of "impending doom"
    • flushing, itching, hives, or feeling warm
    • swelling of the throat or tongue, throat tightness, hoarse voice, or trouble swallowing

    Your healthcare provider will monitor you closely for symptoms of an allergic reaction while you are receiving XOLAIR and for a period of time after your injection. Your healthcare provider should talk to you about getting medical treatment if you have symptoms of an allergic reaction after leaving the healthcare provider's office or treatment center.

    Do not receive XOLAIR if you are allergic to omalizumab or any of the ingredients in XOLAIR.

    Before receiving XOLAIR, tell your healthcare provider about all of your medical conditions, including if you:

    • have any other allergies (such as food allergy or seasonal allergies)
    • have sudden breathing problems (bronchospasm)
    • have ever had a severe allergic reaction called anaphylaxis
    • have or have had a parasitic infection
    • have or have had cancer
    • are pregnant or plan to become pregnant. It is not known if XOLAIR may harm your unborn baby.
    • if you become pregnant while taking XOLAIR, talk to your healthcare provider about registering with the XOLAIR Pregnancy Registry. You can get more information and register by calling 1-866-4XOLAIR (1-866-496-5247) or visit www.XOLAIRpregnancyregistry.com.
    • are breastfeeding or plan to breastfeed. It is not known if XOLAIR passes into your breast milk.

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements.

    How should I receive Xolair?

    • Xolair should be given by your healthcare provider, in a healthcare setting.
    • Xolair is given in 1 or more injections under the skin (subcutaneous), 1 time every 2 or 4 weeks.
    • In asthma patients, a blood test for a substance called IgE must be performed prior to starting Xolair to determine the appropriate dose and dosing frequency. Do not decrease or stop taking any of your other asthma medicine unless your healthcare providers tell you to.
    • You may not see improvement in your symptoms right away after Xolair treatment.

    What are the possible side effects of XOLAIR? XOLAIR may cause serious side effects, including:

    • See, "What is the most important information I should know about XOLAIR" regarding the risk of anaphylaxis.
    • Cancer. People who receive treatment with XOLAIR may have a higher chance for getting certain types of cancer.
    • Fever, muscle aches, and rash. Some people who take XOLAIR get these symptoms 1 to 5 days after receiving a XOLAIR injection. If you have any of these symptoms, tell your healthcare provider.
    • Parasitic infection. Some people who are at a high risk for parasite (worm) infections, get a parasite infection after receiving XOLAIR. Your healthcare provider can test your stool to check if you have a parasite infection.
    • Some people who receive XOLAIR have had chest pain, heart attack, blood clots in the lungs or legs, or temporary symptoms of weakness on one side of the body, slurred speech, or altered vision. It is not known whether this is caused by Xolair.

    The most common side effects of XOLAIR:

    • Pain especially in your arms and legs, dizziness, feeling tired, skin rash, bone fractures, and pain or discomfort of your ears.

    These are not all the possible side effects of XOLAIR. Call your doctor for medical advice about side effects.

    You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555 or Novartis Pharmaceuticals Corporation at 888-669-6682.

    Please see full Prescribing Information, including Medication Guide, for additional important safety information.

    ©2016 Genentech USA, Inc. and Novartis Pharmaceuticals Corporation. All rights reserved.

    This Web site is a service of Genentech USA, Inc. and Novartis Pharmaceuticals Corporation and is intended for U.S. residents only.